Former Diageo Executive Peter McDonough Named CEO Of Trait BiosciencesMay 28, 2019
Vancouver, Canada-based Trait Biosciences, which is focused on cannabinoid production within the cannabis and hemp industries, has named Diageo veteran Peter McDonough as CEO. McDonough, who previously served on Trait’s board, replaces Joseph del Moral, who will continue on the board and work closely with the executive team.
McDonough was a senior executive at Diageo North America for nearly a decade, serving as chief marketing and innovation officer from 2009-2015. Prior to Diageo, he was vice president of European marketing at Procter & Gamble. In addition to McDonough’s appointment, Trait has named Dr. Rebecca White as COO. White was previously vice president, operations, at Qualitas Health. McDonough said White “will play a key role in Trait’s mission to become the most productive originator of technology providing a competitive edge in CBD product development.”
Trait’s proprietary technologies are focused on the “development of enhanced cannabinoids delivering rapid onset, improved efficacy, bioavailability, stability, and taste,” adding that its process for creating water-soluble cannabinoids “does not rely on the use of emulsion or nanotechnology, which are processes of increasing concern by health authorities.”—Daniel MarstellerSubscribe to Shanken News Daily’s Email Newsletter, delivered to your inbox each morning. You will also receive the Cannabis edition as part of your subscription.